Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
R-HCVAD/MTX/ARA-C vs R-Bendamustine in Previously Untreated Mantle Cell Lymphoma
NCT01412879Phase 2Completed
- Sponsor
- SWOG Cancer Research Network
- Start
- Nov 2011
- Primary completion
- Feb 2016
- Modality
- Monoclonal Antibodies, Targeted Liposomes, Orthosteric Ligands
- Countries
- 1
01
Overview
A Phase 2 trial of bendamustine, cyclophosphamide, cytarabine, dexamethasone, pegylated liposomal doxorubicin in mantle cell lymphoma (MCL), sponsored by SWOG Cancer Research Network. Started Nov 2011; status: completed.
02
Drugs
bendamustinecyclophosphamidecytarabinedexamethasonepegylated liposomal doxorubicin
03
Conditions
mantle cell lymphoma (MCL)
Beyond the preview
Go deeper on NCT01412879.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01412879.